Keros Therapeutics, Inc.
Records under this name other than the patents Keros Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
Back to Keros Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 17/945,324 | Methods of Using Activin Receptor Type Iia Variants Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/128,465 | Methods of Using Activin Receptor Type II Variants Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/140,141 | Methods of Treating Lymphopenia Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/289,037 | Activin Receptor Type II Chimeras and Methods of Use Thereof Abandoned Abandoned Oct 12, 2026 | Abandoned | Abandoned Oct 12, 2026 | |
| 18/289,039 | Methods of Using ALK2 and ALK3 Antibodies Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/390,085 | Methods of Using Activin Receptor Type II Signaling Inhibitors Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/443,987 | Methods of Using Activin Receptor Type II Signaling Inhibitors Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/706,647 | Methods of Using ALK2 Inhibitors Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/067,565 | Methods of Administering an Activin Receptor Type Iib Variant Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/077,471 | Activin Receptor Type Iib Variants and Methods of Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |